Short answer
COLLEGIUM PHARMACEUTICAL, INC (COLL) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 financial results announced Feb 26, 2026.
COLLEGIUM PHARMACEUTICAL, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 financial results announced Feb 26, 2026
- Full details in Exhibit 99.1 press release: key figures, guidance, and commentary found there
- "Furnished not filed" status means results won't be incorporated by reference into SEC filings
Item 7.01 · Regulation FD Disclosure
- Collegium Pharmaceutical (COLL) released an earnings presentation on Feb 26, 2026, covering latest reported period results
- Full details in Exhibit 99.2: primary source for revenue, earnings, and guidance figures
- Furnished (not filed) under Reg FD: no SEC liability attached, but content is material for investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other COLLEGIUM PHARMACEUTICAL, INC 8-K filings
Get the next COLL 8-K as it lands
Follow COLL for push alerts, or ask the research agent what this filing means.